Dr. Phil Perera has over 23 years of clinical research experience and has been responsible for the development and approval of small molecule drugs for a variety of CNS and pain disorders. Prior to joining Longboard, Dr. Perera held senior level clinical, scientific, management and business development positions at GlaxoSmithKline, Pharmacia Upjohn, Jazz Pharmaceuticals, Pfizer, the Parkinson’s Institute and Dart NeuroScience. He is a graduate of Harvard Medical School and a board-certified Psychiatrist. He also holds a M.B.A. from Arizona State University. Prior to working in the pharmaceutical industry Dr. Perera was on the faculty of New York Hospital, Cornell Medical College as Chief of Inpatient and Day Treatment Psychiatric Services at North Shore University Hospital, and he was a practicing adult and geriatric psychiatrist. He is also a past Board member of the American Society for Experimental Neurotherapeutics. Dr. Perera has published numerous clinical research papers across neurologic and psychiatric conditions.